NewsBite

Australian Pharmaceutical Industries

Advertisement
From botox to telehealth: Why Bunnings’ owner is chasing wellness

From botox to telehealth: Why Bunnings’ owner is chasing wellness

Speculation that Wesfarmers is eyeing telehealth business InstantScripts is another reminder that the retail giant wants access to the health and wellness industry.

  • by Emma Koehn

Latest

‘No-brainer’: Woolies muscles into telehealth

‘No-brainer’: Woolies muscles into telehealth

Consumers will be able to log on for everything from a doctor’s certificate to dietitian consultations via the grocery giant’s new wellness arm.

  • by Emma Koehn
Woolworths withdraws bid for Priceline owner API

Woolworths withdraws bid for Priceline owner API

Wesfarmers is now the frontrunner to take over the company that also owns the Soul Pattinson Chemist and Pharmacist Advice chains.

  • by Sarah Danckert
Woolworths boss promises he’s not here to ‘disrupt’ pharmacies

Woolworths boss promises he’s not here to ‘disrupt’ pharmacies

The supermarket giant’s chief executive Brad Banducci has sought to allay concerns from pharmacy owners over the company’s bid to acquire Priceline operator API.

  • by Dominic Powell
Wesfarmers issues Woolies warning to pharmacists as Priceline battle heats up

Wesfarmers issues Woolies warning to pharmacists as Priceline battle heats up

Wesfarmers has taken its campaign to win a takeover battle with Woolworths for the Priceline chain directly to pharmacists.

  • by Dominic Powell
After COVID, the battle for the future of the pharmacy begins

After COVID, the battle for the future of the pharmacy begins

Renewed interest from retailers to buy an Australian pharmacy brand has reopened the question of what the chemist of the future should look like.

  • by Emma Koehn
Advertisement
API board backs Wesfarmers’ raised offer for Priceline owner

API board backs Wesfarmers’ raised offer for Priceline owner

Retail giant Wesfarmers appears in pole position to take over pharmaceutical wholesaler Australian Pharmaceutical Industries (API) after sweetening its offer.

  • by Emma Koehn and Dominic Powell
M&A boom predicted after companies sit on $40 billion cash pile

M&A boom predicted after companies sit on $40 billion cash pile

Ongoing COVID lockdowns are not expected to stop companies opening the purse strings to pursue acquisitions or return cash to investors via buybacks and dividends. 

  • by Colin Kruger
Wesfarmers likely to lob fresh bid after API rejects $687m offer

Wesfarmers likely to lob fresh bid after API rejects $687m offer

Shareholders in takeover target API believe it’s likely Wesfarmers will make a higher offer after having its initial bid rejected by the company’s board.

  • by Dominic Powell
Wesfarmers kicks off pharmacy foray with $687m Priceline bid

Wesfarmers kicks off pharmacy foray with $687m Priceline bid

Wesfarmers is hoping to establish itself as a sizable player in Australia’s $20 billion pharmacy industry after a surprise bid for local pharmaceutical retailer API.

  • by Dominic Powell
Priceline ‘waiting for green light’ to help with vaccine rollout

Priceline ‘waiting for green light’ to help with vaccine rollout

Priceline boss Richard Vincent says pharmacy wholesalers are ready to play a bigger role in the distribution COVID vaccines across the country as the national cabinet is considering plans to fast-track the process.

  • by Emma Koehn

Original URL: https://www.brisbanetimes.com.au/topic/api-7a